GlaxoSmithKline Pakistan Limited announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was PKR 36,581.749 million compared to PKR 34,006.840 million a year ago. Operating income was PKR 4,889.907 million compared to PKR 4,839.509 million a year ago. Net income was PKR 3,041.123 million compared to PKR 3,257.951 million a year ago. Basic earnings per share from continuing operations was PKR 9.55 compared to PKR 10.15 a year ago. Basic earnings per share was PKR 9.55 compared to PKR 10.23 a year ago.